| Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis ML Bastos, G Tavaziva, SK Abidi, JR Campbell, LP Haraoui, JC Johnston, ... bmj 370, 2020 | 982 | 2020 |
| Whole-genome sequencing and social-network analysis of a tuberculosis outbreak JL Gardy, JC Johnston, SJH Sui, VJ Cook, L Shah, E Brodkin, S Rempel, ... New England Journal of Medicine 364 (8), 730-739, 2011 | 888 | 2011 |
| Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis JC Johnston, NC Shahidi, M Sadatsafavi, JM Fitzgerald PloS one 4 (9), e6914, 2009 | 592 | 2009 |
| Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ... Nature genetics 45 (7), 784-790, 2013 | 516 | 2013 |
| Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis MR Farhat, BJ Shapiro, KJ Kieser, R Sultana, KR Jacobson, TC Victor, ... Nature genetics 45 (10), 1183-1189, 2013 | 508 | 2013 |
| Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing CRyPTIC Consortium and the 100,000 Genomes Project New England Journal of Medicine 379 (15), 1403-1415, 2018 | 325 | 2018 |
| A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations AS Shah, AW Wong, CJ Hague, DT Murphy, JC Johnston, CJ Ryerson, ... Thorax 76 (4), 402-404, 2021 | 220 | 2021 |
| Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis K Romanowski, B Baumann, CA Basham, FA Khan, GJ Fox, JC Johnston The Lancet Infectious Diseases 19 (10), 1129-1137, 2019 | 218 | 2019 |
| Patient-reported outcome measures after COVID-19: a prospective cohort study AW Wong, AS Shah, JC Johnston, C Carlsten, CJ Ryerson European Respiratory Journal 56 (5), 2020 | 198 | 2020 |
| The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ... The Lancet Microbe 3 (4), e265-e273, 2022 | 149 | 2022 |
| Tuberculosis and chronic kidney disease: an emerging global syndemic K Romanowski, EG Clark, A Levin, VJ Cook, JC Johnston Kidney international 90 (1), 34-40, 2016 | 143 | 2016 |
| Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis F Fregonese, SD Ahuja, OW Akkerman, D Arakaki-Sanchez, I Ayakaka, ... The Lancet Respiratory Medicine 6 (4), 265-275, 2018 | 104 | 2018 |
| Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis P Weiss, W Chen, VJ Cook, JC Johnston BMC infectious diseases 14, 1-9, 2014 | 99 | 2014 |
| Chest x-ray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: a prospective study of diagnostic accuracy for culture-confirmed disease FA Khan, A Majidulla, G Tavaziva, A Nazish, SK Abidi, A Benedetti, ... The Lancet Digital Health 2 (11), e573-e581, 2020 | 94 | 2020 |
| Diagnostic accuracy of stool Xpert MTB/RIF for detection of pulmonary tuberculosis in children: a systematic review and meta-analysis E MacLean, G Sulis, CM Denkinger, JC Johnston, M Pai, F Ahmad Khan Journal of clinical microbiology 57 (6), 10.1128/jcm. 02057-18, 2019 | 94 | 2019 |
| Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis JP Samuels, A Sood, JR Campbell, FA Khan, JC Johnston Nature Scientific reports 8 (1), 4980, 2018 | 88 | 2018 |
| Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis K Al-Efraij, L Mota, C Lunny, M Schachter, V Cook, J Johnston The International journal of tuberculosis and lung disease 19 (12), 1493-1499, 2015 | 84 | 2015 |
| Mycobacterium kasasii EK Johnston JC, Chiang L Microbiology Spectrum 5 (1), 2017 | 59* | 2017 |
| Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis K Romanowski, RF Balshaw, A Benedetti, JR Campbell, D Menzies, ... Thorax 74 (3), 291-297, 2019 | 58 | 2019 |
| Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials JR Campbell, A Trajman, VJ Cook, JC Johnston, M Adjobimey, R Ruslami, ... The Lancet Infectious Diseases 20 (3), 318-329, 2020 | 54 | 2020 |
Victoria CookUniversity of British Columbia在 bccdc.ca 的电子邮件经过验证
